val-cit-pab-mmae — TargetMol Chemicals

Cat No.	Product Name	Synonyms	Targets
T18867	Val-Cit-PAB-MMAE
	Val-Cit-PAB-MMAE is a drug-linker conjugate for ADC. Val-Cit-PAB-MMAE contains the ADCs linker (peptide Val-Cit-PAB) and a potent tubulin inhibitor MMAE . MMAE a potent mitotic inhibitor by inhibiting tubulin polymerizat...
T17983	Fmoc-Val-Cit-PAB-MMAE		Others
	Fmoc-Val-Cit-PAB-MMAE is consisted of the ADCs linker (Fmoc-Val-Cit-PAB) and potent tubulin inhibitor (MMAE). Fmoc-Val-Cit-PAB-MMAE is a drug-linker conjugate for ADC.		Others
T39307	Azido-PEG4-Val-Cit-PAB-MMAE	Azido-PEG4-Val-Cit-PAB-MMAE
	Azido-PEG4-Val-Cit-PAB-MMAE is a drug-linker conjugate for antibody-drug conjugates (ADCs), comprising the anti-mitotic agent monomethyl auristatin E (MMAE, a tubulin inhibitor), connected through the cleavable linker Az...
T39328	SuO-Glu-Val-Cit-PAB-MMAE
	SuO-Glu-Val-Cit-PAB-MMAE is a chemical compound comprising a cleavable ADC linker, SuO-Glu-Val-Cit-PAB, and a potent tubulin inhibitor known as MMAE. It is utilized in the synthesis of antibody-drug conjugates (ADCs).
T77876	Py-MAA-Val-Cit-PAB-MMAE	AAJ8D6-PY-Val-Cit-MMAE
	Py-MAA-Val-Cit-PAB-MMAE (AAJ8D6-PY-Val-Cit-MMAE) serves as an ADC linker for Zapadcine-3a, a broad-spectrum anti-TRAILR2 ADC with antineoplastic properties. By targeting TRAILR2, Zapadcine-3a is internalized into the lys...
T18736	SuO-Val-Cit-PAB-MMAE		Others
	SuO-Val-Cit-PAB-MMAE is an ADC (antibody-drug conjugate) linker comprising the anti-mitotic monomethyl auristatin E (MMAE, a tubulin inhibitor) connected through the SuO-Val-Cit-PAB peptide.		Others
T17938	Endo-BCN-PEG4-Val-Cit-PAB-MMAE		Others
	Endo-BCN-PEG4-Val-Cit-PAB-MMAE is a cleavable four-unit polyethylene glycol (PEG) linker, specifically designed for the synthesis of antibody-drug conjugates (ADCs)[1].		Others
T18250	MAL-di-EG-Val-Cit-PAB-MMAE		Others
	MAL-di-EG-Val-Cit-PAB-MMAE comprises the linker MAL-di-EG-Val-Cit-PAB and the potent tubulin inhibitor MMAE, which are essential components of antibody-drug conjugates (ADCs).		Others
T17435	Amino-PEG4-Val-Cit-PAB-MMAE		Others
	Amino-PEG4-Val-Cit-PAB-MMAE is a cleavable tetraethylene glycol (4 unit PEG) antibody-drug conjugate (ADC) linker employed in the synthesis of ADCs[1].		Others
T18299	Mal-PEG8-Val-Cit-PAB-MMAE		Others
	Mal-PEG8-Val-Cit-PAB-MMAE is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1].		Others
T67428	MDPR-Val-Cit-PAB-MMAE
	mDPR-Val-Cit-PAB-MMAE consists the ADCs linker (mDPR-Val-Cit-PAB) and potent tubulin inhibitor (MMAE), mDPR-Val-Cit-PAB-MMAE is an antibody drug conjugate.
T81361	PSMA-Val-Cit-PAB-MMAE
	PSMA-Val-Cit-PAB-MMAE is a novel PSMA-targeted small-molecule conjugate leveraging monomethyl auristatin E (MMAE) for prostate cancer chemotherapy.
T77866	OH-Glu-Val-Cit-PAB-MMAE
	OH-Glu-Val-Cit-PAB-MMAE is a compound comprising a cleavable ADC linker (OH-Glu-Val-Cit-PAB) and a potent tubulin inhibitor (MMAE), utilized in the synthesis of antibody-drug conjugates (ADCs) [1].
T77885	(Aminooxy)acetamide-Val-Cit-PAB-MMAE
	(Aminooxy)acetamide-Val-Cit-PAB-MMAE (MMAE 5) serves as an intermediate for synthesizing drug-linker conjugates in antibody-drug conjugates (ADCs). This compound is first conjugated to a polyamide through oxime bond form...
T18321	Mc-Val-Cit-PAB-Cl		Others
	Mc-Val-Cit-PAB-Cl, a cleavable ADC linker, is utilized in the conjugation of MMAE and antibodies to produce compounds such as antibody-MC-vc-MMAE (e.g., anti-CD22-MC-VC-PABC-MMAE), which demonstrate cytotoxicity with IC5...		Others
T77839	Bi-Mc-VC-PAB-MMAE
	Bi-Mc-VC-PAB-MMAE is an agent-linker conjugate for antibody-drug conjugates (ADCs), featuring the linker (Fmoc-Val-Cit-PAB) and the potent tubulin inhibitor (MMAE).
T80884	Val-Cit-amide-Ph-Maytansine
	Val-Cit-PAB-MMAE is a molecular entity designed to function as an antibody-drug conjugate (ADC) or as a component of bispecific antigen-binding molecules, specifically targeting the hepatocyte growth factor receptor know...
T77892	Mal-PEG8-Val-Cit-PAB-MMAF
	Mal-PEG8-Val-Cit-PAB-MMAF is a drug-linker conjugate utilized for antibody-drug conjugates (ADCs), comprising a cleavable linker system and the potent tubulin inhibitor monomethyl auristatin F (MMAF), aimed at targeted c...